These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9600212)

  • 1. The extracellular matrix in multiple sclerosis lesions.
    Sobel RA
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):205-17. PubMed ID: 9600212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular matrix in multiple sclerosis: an update.
    Sobel RA
    Braz J Med Biol Res; 2001 May; 34(5):603-9. PubMed ID: 11323746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).
    de Jong JM; Wang P; Oomkens M; Baron W
    J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.
    Sobel RA; Ahmed AS
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1198-207. PubMed ID: 11764092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular matrix in multiple sclerosis pathology.
    van Horssen J; Dijkstra CD; de Vries HE
    J Neurochem; 2007 Nov; 103(4):1293-301. PubMed ID: 17854386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
    Maeda A; Sobel RA
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system.
    Haylock-Jacobs S; Keough MB; Lau L; Yong VW
    Autoimmun Rev; 2011 Oct; 10(12):766-72. PubMed ID: 21664302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling.
    Gutowski NJ; Newcombe J; Cuzner ML
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):207-14. PubMed ID: 10417662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions.
    Rayatpour A; Javan M
    Pharmacol Res; 2021 May; 167():105441. PubMed ID: 33503478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix-cell interactions: Focus on therapeutic applications.
    Sainio A; Järveläinen H
    Cell Signal; 2020 Feb; 66():109487. PubMed ID: 31778739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFL7 reduces CNS inflammation in mouse.
    Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
    Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro.
    Bridel C; Koel-Simmelink MJA; Peferoen L; Derada Troletti C; Durieux S; Gorter R; Nutma E; Gami P; Iacobaeus E; Brundin L; Kuhle J; Vrenken H; Killestein J; Piersma SR; Pham TV; De Vries HE; Amor S; Jimenez CR; Teunissen CE
    Neuropathol Appl Neurobiol; 2018 Jun; 44(4):404-416. PubMed ID: 28543098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes.
    van Horssen J; Bö L; Vos CM; Virtanen I; de Vries HE
    J Neuropathol Exp Neurol; 2005 Aug; 64(8):722-9. PubMed ID: 16106221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schwann cell extracellular matrix molecules and their receptors.
    Chernousov MA; Carey DJ
    Histol Histopathol; 2000 Apr; 15(2):593-601. PubMed ID: 10809381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.
    Tomlin H; Piccinini AM
    Immunology; 2018 Oct; 155(2):186-201. PubMed ID: 29908065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular matrix in myocardial injury, repair, and remodeling.
    Frangogiannis NG
    J Clin Invest; 2017 May; 127(5):1600-1612. PubMed ID: 28459429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system.
    Engin AB; Nikitovic D; Neagu M; Henrich-Noack P; Docea AO; Shtilman MI; Golokhvast K; Tsatsakis AM
    Part Fibre Toxicol; 2017 Jun; 14(1):22. PubMed ID: 28646905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix structure.
    Theocharis AD; Skandalis SS; Gialeli C; Karamanos NK
    Adv Drug Deliv Rev; 2016 Feb; 97():4-27. PubMed ID: 26562801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Ghorbani S; Yong VW
    Brain; 2021 Aug; 144(7):1958-1973. PubMed ID: 33889940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.